AMBICION
AMBICION develops new drugs focused on establishing a global standard treatment for cancer patients. The company's is called product Natural killer T cells or NKT cells, a type of T cells that also have NK cell properties. It is activated by recognizing glycolipid antigens, produce many types of cytokines, and induce both immunostimulation and suppression reactions. NKT cells can induce cell death to cancer cells due to the nature of NK cells, but its direct cytotoxic activity is limited due to the small amount present in the body. NKT cells also have the ability to produce large amounts of cytokines. AMBICION was founded in October 2015 and is headquartered in Tokyo, Japan.
AMBICION
Industry:
Biotechnology Health Care Medical Nursing And Residential Care Product Research Wellness
Founded:
2015-10-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.ambicion.co.jp
Total Employee:
1+
Status:
Active
Contact:
03-5357-7231
Email Addresses:
[email protected]
Total Funding:
6.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
GenoMembrane
GenoMembrane provides both SLC transporters and ABC transporter Vesicles/reagents for you to facilitate drug discovery
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Current Employees Featured
Investors List
Regional Health Care Industry Support Fund
Regional Health Care Industry Support Fund investment in Venture Round - AMBICION
Toho Holdings
Toho Holdings investment in Venture Round - AMBICION
REVIC
REVIC investment in Venture Round - AMBICION
REVIC
REVIC investment in Venture Round - AMBICION
Regional Health Care Industry Support Fund
Regional Health Care Industry Support Fund investment in Venture Round - AMBICION
Official Site Inspections
http://www.ambicion.co.jp
- Host name: 153.122.205.14
- IP address: 153.122.205.14
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "AMBICION"
Company Profile Company Profile - ambicion.co.jp
1-minute walk from Yotsuya-sanchome Station on Tokyo Metro Marunouchi LineSee details»
Ambicion
Research, development, production of cell medicines and ethical drugsSee details»
Company Profile - ambicion.co.jp
Company Profile Company Profile Message from the CEO Company Philosophy Company Profile Scientific Advisers TOP Company Profile Please make your inquiries Inquiries ...See details»
Ambicion Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Ambicion. Use the PitchBook Platform to explore the full profile.See details»
AMBICION - Crunchbase Company Profile & Funding
AMBICION is a pharmaceutical company that develops innovative cancer treatments that address unmet medical needs.See details»
Ambicion - Overview, News & Similar companies | ZoomInfo.com
View Ambicion (www.ambicion.co.jp) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
AMBICION Information - RocketReach
AMBICION is a Chemicals, Petrochemicals, Glass & Gases, Health Care, and Manufacturing company_reader located in Tokyo, Tokyo with $2 million in revenue and 0 employees. Find โฆSee details»
AMBICION, LIMITED LIABILITY CO. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AMBICION, LIMITED LIABILITY CO. of SHIBUYA-KU, TOKYO. Get the latest business insights from Dun โฆSee details»
AMBICION CO., LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AMBICION CO., LTD. of SHINJUKU-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
AMBICION | Company | Mindmaps
Technology:Small Molecules Founded Date:2015 Visit Website [email protected] Register and Claim OwnershipSee details»
AMBICION Reviews | Read Client Reviews of AMBICION.
Read reviews of AMBICION. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Ambicion Co. Ltd. - BioCentury Company Profiles - BCIQ
Ambicion Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Ambicion - Products, Competitors, Financials, Employees, โฆ
Ambicion's headquarters is located at Wako Building, 5th Floor, Tokyo. What is Ambicion's latest funding round? Ambicion's latest funding round is Unattributed VC. How much did Ambicion โฆSee details»
Yoshiyuki Saito - Chief Executive Officer - Ambicion | ZoomInfo
AMBICION and RIKEN Enter into the Global Exclusive Licensing Agreements for Natural Killer T (NKT) Cell-Targeted Anti-Cancer Therapy ๏ฝ News - Ambicion Mar 30, 2018 ambicion.co.jp โฆSee details»
Company Profile Company Philosophy - ambicion.co.jp
Company Profile Company Philosophy We contribute to the healthy lives of people through blazing a new path in the world of medicineSee details»
Company Profile Message from the CEO - ambicion.co.jp
Company Profile Message from the CEO AMBICION is the Spanish word for โambitionโ. While Professor William S. Clarkโs words to Japanese students, โBoys, be ambitious!โ is a famous โฆSee details»
Venture Round - AMBICION - 2018-04-18 - Crunchbase
Recent News News โข Apr 18, 2018 marketscreener.com โ Toho : Announcement about Capital Alliance with AMBICION Co., Ltd. News โข Apr 17, 2018 ambicion.co.jp โ AMBICION has โฆSee details»
Ambicion Management Team - CB Insights
Explore {Ambicion's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Ambicion Stock Price, Funding, Valuation, Revenue ... - CB Insights
Apr 18, 2018 See Ambicion funding rounds, investors, investments, exits and more. Evaluate their financials based on Ambicion's post-money valuation and revenue.See details»
Technology - ambicion.co.jp
Technology Technology Natural Killer T (NKT) Cells NKT cell functions Mechanisms of NKT cell-targeted cancer immunotherapy Advantages of NKT cell-targeted cancer immunotherapy โฆSee details»